Pakistan Journal of
Neurological Sciences (PJNS)
Volume 8 | Issue 1

Article 5

1-2013

not all asymptomatic carotid plaques are equal:
some require intervention
Iram Naz
Aga Khan University Hospital Karachi,pakistan, iram.naz@aku.edu

Follow this and additional works at: http://ecommons.aku.edu/pjns
Part of the Neurology Commons
Recommended Citation
Naz, Iram (2013) "not all asymptomatic carotid plaques are equal: some require intervention," Pakistan Journal of Neurological Sciences
(PJNS): Vol. 8 : Iss. 1 , Article 5.
Available at: http://ecommons.aku.edu/pjns/vol8/iss1/5

R E V I E W

A R T I C L E

NOT ALL ASYMPTOMATIC CAROTID PLAQUES ARE EQUAL:
SOME REQUIRE INTERVENTION
Dr. Iram Naz

Section of vascular surgery, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan
Correspondence to: Iram Naz, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan; iram.naz@aku.edu

ABSTRACT:
Ischemic stroke represents a major health hazard around the world, which has a severe impact on society and the
health-care systems. Roughly, 15% of all strokes can be attributed to significant atherosclerotic disease of the carotid
arteries. Some patients presenting with disabling strokes for the first time cannot benefit from carotid revascularization
having lost the opportunity of prevention. We know that all symptomatic patients were once asymptomatic. Hence,
after identifying high risk carotid plaques and patient's characteristics suitable for interventions, they should be offered
carotid revascularization at specialized centers (with low perioperative stroke and death rates) to prevent stroke and
cognitive function decline in long term.
INTRODUCTION:

Some authors think that current risk of stroke in
asymptomatic patients on best medical therapy is less
than 1%, so >95% of the cases should be left untreated.
6, 7, 8 In addition, significant improvements in Best
Medical Therapy (BMT) have occurred over time,
especially lipid lowering drugs (used in only 10% of
patients in the ACST trial and in 80% at 10-year followup) 9, 10. Addition of CAS to carotid revascularization
has further confused the data as it has high perioperative
stroke rate as compared to CEA11.

Extra cranial carotid artery atherosclerosis is one
potentially preventable risk factor for Stroke worldwide.
The locations most frequently affected by carotid
atherosclerosis are the proximal internal carotid artery
(i.e., the origin) and the carotid bifurcation. Progression
of atheromatous plaque at the carotid bifurcation results
in luminal narrowing, often accompanied by ulceration.
This process can lead to an ischemic stroke or transient
ischemic attack (TIA) from embolization, thrombosis,
or hemodynamic compromise. Asymptomatic patients
are usually identified after auscultation of bruits or
patients undergoing Coronary Artery Bypass Grafting
(CABG) in our country, as routine screening for patients
at high risk is not practiced here. Various risk factors,
management options (best medical therapy(BMT),
carotid interventions) have been studied in randomized
trials around the world and international guidelines
have been developed for intervention for symptomatic
and asymptomatic carotid artery disease 1,2,3,4. All
recent guidelines recommend considering Carotid
endarterectomy (CEA) in patients with a 60-99% NASCET
asymptomatic stenosis 5. All guidelines demand a low
perioperative stroke and death rate (2-3%) 1, 2,3,4,5.
The real question arises which asymptomatic plaques
will benefit more from carotid revascularization. This
review article aims to describe an approach to such
asymptomatic patients and the challenges of
management in Pakistan.

Treatment of ACS: Pros
Repair of carotid stenosis, in addition to best medical
therapy (BMT), is currently the best way to treat most
asymptomatic patients with 60% to 99% carotid stenosis.
Carotid stenosis causes preventable strokes. After a
significant carotid stenosis has developed, that lesion
remains a threat to the patient until it is removed. In
the Asymptomatic Carotid Surgery Trial (ACST) 9 the
annual risk of stroke after repair (0.55%) was much
less than the annual risk with BMT alone (1.9%). The
Asymptomatic Carotid Atherosclerosis Study (ACAS) 12
and ACST studies both compared carotid endarterectomy
(CEA) plus BMT vs BMT alone, and both studies
demonstrated a decreased risk of stroke by approximately
50% at 5 years, even though both studies were biased
against repair9, 11. In addition; some carotid plaque
may not response to BMT as stroke risk is never zero
in many trials worldwide.
Over time, there has been a standardization of technique
for carotid endarterectomy by vascular surgeons resulting
in reduced perioperative morbidity and mortality.

Treatment of asymptomatic Carotid Stenosis
(ACS): Cons:
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Perioperative stroke and death rate for CEA in
asymptomatic patients have gone down from 3.1% in
ACST trial9 to 1.1% in CREST trial. In the real world,
surgeons must have such low incidence to offer CEA
to asymptomatic patients.

years.10
Factors influencing benefit and risk:
A number of factors may influence the risk/benefit ratio
with endarterectomy and thus decision to treat individual
patients with asymptomatic carotid disease. The selection
of asymptomatic patients should be guided by an
assessment of co-morbid conditions, life expectancy,
and other individual factors and should include a
thorough discussion of the risks and benefits of the
procedure with an understanding of patient preference.
Patients who are unlikely to benefit from CEA include
those who have severe comorbidity due to other medical
or surgical illness, patients with a prior ipsilateral stroke
associated with persistent disabling neurologic deficits,
and patients with total occlusion of the internal carotid
artery.

The unfortunates who present with stroke due to carotid
stenosis (and their even more unfortunate counterparts
who experienced a fatal stroke as the first sign of
trouble) all harbored an asymptomatic lesion before
their respective events. Carotid repair used judiciously
in concert with BMT and performed well can have lifelong protective effects against stroke-related death and
disability for patients with asymptomatic carotid stenosis
9, 12, 13. Vadimir 14, phil Gorelick 15 and others 16,
have taught us that silent strokes become evident
largely through cognitive decline. Once the great scientist
in 1672, Thomas Willis said "Foolishness may also
result from great Strokes". Also, the incidence of silent
strokes may be as high as 9-fold as that of evident
strokes 17. These statistics are from the United States.
We don't know our statistics in Pakistan. Recently,
Akiko Takaiwa18 demonstrates improvement of cognitive
function in asymptomatic patients by revascularization.
This was limited to a very small group of 15 patients.

1. Gender: The benefit of CEA appears to be greater
for men than for women with asymptomatic carotid
disease. (ACST)19.
2. Risk Stratification:
a) Asymptomatic embolism: Transcranial Doppler
Ultrasound (TCD) is a non-invasive technique that
can be used to detect circulating emboli. If clinical
embolism is a good predictor of the subsequent
risk, asymptomatic cerebral emboli might also predict
clinical stroke risk 20. Recently, a large prospective
and multi-center study (ACES, asymptomatic Carotid
emboli study) evaluated the relationship between
asymptomatic emboli and stroke risk in 467 patients
with an ACS of at least 70%. The detection of emboli
was associated with an increased risk for ipsilateral
TIA and stroke (HR 2.54,95% CI 1.2-5.36) and in
particular for ipsilateral stroke (HR 5.57,95% CI
1.61-19.32) during 2 years of follow-up even after
adjusting for antiplatelet therapy, degree of stenosis,
and other risk factors.

The Role of Carotid Endarterectomy in ACS:
Guidelines on CEA for asymptomatic carotid stenosis
are largely based on the result of 2 large, randomized
studies of CEA versus BMT; ACAS, and ACST. The ACAS
trial randomized 1662 adults (Ages 40 to 79 years)
with 60-99% carotid stenosis. They followed up the
patients at 2.7 years. The aggregate risk over 5 years
for ipsilateral stroke and any perioperative stroke or
death was estimated to be 5.15 for surgical patients
and 11.0% for patients treated medically, an aggregate
risk reduction of 53% (95 Confidence Interval,
22%-72%).
In the ACST, 3120 patients with over 60% mainly
asymptomatic carotid stenosis were randomized to
either immediate CEA plus medical treatment versus
medical treatment alone or until the operation became
necessary. ACST-1 reported 10 year stroke prevention,
combining perioperative events and strokes. Net risks
were 6.9%versus 10.95 at 5 years (gain 4-1%, 2.06.2) and 13.4% versus 17.9% at 10 years (gain 4.65,
1.2-7.9). They concluded that net benefit in future
patients will depend on their risks from unoperated
carotid lesions (which will be reduced by medication),
or future surgical risks (which might differ from those
in trials) and on whether life expectancy exceeds 10
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b) Carotid plaque morphology:Carotid plaque
echolucency measurement by grey scale
Measurement 2 1 and recently, data from
ACES demonstrated that plaque morphology
assessed using a simple visual rating scale predicts
ipsilateral stroke in ACS22. 435 patients with ACS
70% were included and followed-up for 2 years.
Plaque echolucency at baseline was associated with
an increased risk of ipsilateral stroke alone (HR
6.43, 95% CI 1.36-30.44).A combination of plaque
echolucency and ES positivity was associated with
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good surgical candidates. Neither SAPPHIRE nor
CREST29 trials address the question now posed by
improvement in BMT, namely whether patients with
ACS should undergo any revascularization procedure.
The Transatlantic asymptomatic carotid intervention
trial will investigate current BMT in combination with
CEA or CAS compared with BMT alone in patients with
asymptomatic carotid disease30. Few other trials are
currently in progress including SPACE 2 study.

increased risk of ipsilateral stroke alone (HR 10.61,
95% CI 2.98-37.820. The combination of ES
detection and plaque morphology allows a greater
prediction and identifies a high risk group with an
annual stroke risk of 8%, and a lower risk group
with a risk of <1% per year.22
c) Magnetic Resonance Imaging (MRI) of plaque:
MRI is a non-invasive method of plaque measurement
that does not involve ionizing radiation. Initial result
from a prospective study demonstrated an increased
risk of ipsilateral cerebrovascular events has also
been reported over a mean follow-up period of 38.2
months in asymptomatic patients who had 50-79%
stenosis and the presence of a thin or ruptured
fibrous cap, intraplaque hemorrhage, or a larger
lipid rich necrotic core.23

Current status of Stroke and stoke care in Pakistan:
No large scale epidemiological studies are available to
determine the true incidence of stroke in Pakistan.
Estimated annual incidence is 250/100,000, translating
to 350,000 new cases every year. Stroke related
mortality in the acute stage has been reported in the
range of 11-30% 31. Large artery atherosclerosis
accounted for 26.9% of all stroke in 393 patients
presenting with stroke, less than lacunar subtype from
the Aga Khan University Stroke data bank 32. Few
studies reported on carotid diseases, ranged from 719% 33, 34, but these were among patients presented
with neurological events so were not asymptomatic
patients. A study from Pakistan reported low frequency
of carotid atheromatous disease in patients with recent
stroke or TIA35. They performed carotid Doppler at two
centers. Potentially surgically correctable disease,
defined as 70-99% carotid artery stenosis was present
in only 79/672(12%) cases. Only 4 (0.5%) underwent
intervention meaning a low utilization of procedures.
Various factors were discussed for this underutilization.
These included lack of awareness about prevention of
stroke by intervention, on part of the physician or the
physicians may have considered those patients not
candidates for surgery. Other factors include self pay
status of many middle and poor class patients and
significant price variation for health care (physician fee,
diagnostic work up and hospitalization) as compared
to developed countries. There are very few studies on
safety of carotid endarterectomy in Pakistan. During a
10 year period, 59 patients underwent carotid
endarterectomy at single center by single vascular
surgeon, 11 of which underwent simultaneous coronary
artery bypass grafting (CABG). Mortality was 27% in
patients undergoing CEA and CABG versus 2%
undergoing CEA alone36.

3. Stroke heterogeneity: Strokes occurring in the
territory of an ACS are not always caused by carotid
lesion. Indeed, data from NASCET 5 show that almost
50% of the strokes in the territory of a greater than
60% ACS are due to small vessel disease ("lacunar")
and cardio embolic disease.24
4. Contra lateral carotid artery stenosis or
occlusion: The findings on this are conflicting in
literature. Mostly Authors suggest no benefit of
intervention in high grade stenosis with contra lateral
occlusion.25
5. Degree of stenosis:
Neurologically asymptomatic patients with >60%
NASCET stenosis, should be considered for CEA provided
the patient has a 3-5 year life expectancy and perioperative stroke/death rates of 3% or less. 3
Coronary arteries bypass grafting (CABG) Surgery
in the presence of asymptomatic high grade carotid
stenosis:
Studies suggest that previous or simultaneous CEA in
patients with unilateral severe asymptomatic carotid
stenosis undergoing CABG could prevent stroke better
than delayed CEA, without increasing the overall surgical
risk.26, 27, 28
Role of Carotid stenting in Asymptomatic Carotid
stenosis:

An Audit in 2012 (unpublished data) showed increased
number of CEA from the same center. 157 patients
undergoing CEA between 1990 and Feb 2012 were
included (59 patients of previously published study 36
are included). There were 123 Males. 34 patients had

There is no data at present to support the preferential
use of CAS over CEA in asymptomatic patients that are
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simultaneous CEA and CABG. Perioperative stroke rate
was 3.1% in carotid endarterectomy alone and 5.1%
in combined CEA and CABG group.

with a threatening lesion, and the potential of
long-term cognitive deterioration.
We as a scientific community should strive to create
new knowledge about management of asymptomatic
carotid stenosis in developing countries as we cannot
afford high cost screening and stoke care as offered in
Europe and North America. Till then, we have to use
their data and individualize care of our patients.

Two centers have published results of carotid stenting
in Pakistan 37, 38. They were performed for various
indications, in high risk group, mostly unfit for surgical
intervention.
How to approach Asymptomatic Carotid stenosis
patient in 2013?

CONCLUSIONS:

Any patient diagnosed to have a bruit on clinical
examination or found to have high grade stenosis >70%
on carotid Doppler ultrasound, should be evaluated
further for identifying vulnerable plaques by TCD,
echolucency and ulceration on ultrasound, MRI of
plaque, or biomarkers when available. Based on
individual characteristics e.g. life expectancy with
availability of centers with low perioperative stroke/death
rate of <3% of CEA, patients should be counseled
about risk reduction by CEA. High risk candidates can
be offered CAS, if risk of stroke is very high. 1

Until we get epidemiological data on frequency and
outcome of carotid artery disease in Pakistan, we cannot
deprive our high stroke risk patients from carotid
interventions. There is a need for more collaboration
with neurologist community for early referrals. And
emphasis for an international stroke nongovernmental
organization to reach a consensus on comprehensive
stroke prevention strategies in south Asia. Till then, we
should continue to provide carotid repair to good-risk
patients with significant asymptomatic carotid stenosis
and continue to look for ways to identify patients most
likely to benefit from repair.

Future of Stroke prevention in Pakistan:
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